Close to a fifth of bowel disease patients have joint conditions like spondyloarthritis and peripheral arthritis, a Texas study reports.
Ana Belo van Wijk, PhD
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Ana Belo van Wijk, PhD
Xeljanz (tofacitinib) showed promising results for ankylosing spondylitis (AS) patients in a 16-week Phase 2 clinical trial. AS patients with…